Winning Health Technology Group Co., Ltd.

SZSE:300253 Stock Report

Market Cap: CN¥15.3b

Winning Health Technology Group Future Growth

Future criteria checks 3/6

Winning Health Technology Group is forecast to grow earnings and revenue by 98.9% and 13% per annum respectively. EPS is expected to grow by 98.3% per annum. Return on equity is forecast to be 3.5% in 3 years.

Key information

98.9%

Earnings growth rate

98.31%

EPS growth rate

Healthcare Services earnings growth38.6%
Revenue growth rate13.0%
Future return on equity3.54%
Analyst coverage

Low

Last updated14 May 2026

Recent future growth updates

Recent updates

Analysis Article • Mar 23

Winning Health Technology Group (SZSE:300253) Is Reinvesting At Lower Rates Of Return

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article • Feb 07

After Leaping 43% Winning Health Technology Group Co., Ltd. (SZSE:300253) Shares Are Not Flying Under The Radar

Winning Health Technology Group Co., Ltd. ( SZSE:300253 ) shares have had a really impressive month, gaining 43% after...
Analysis Article • Nov 05

There May Be Underlying Issues With The Quality Of Winning Health Technology Group's (SZSE:300253) Earnings

Winning Health Technology Group Co., Ltd.'s ( SZSE:300253 ) robust earnings report didn't manage to move the market for...
Analysis Article • Oct 10

Winning Health Technology Group Co., Ltd. (SZSE:300253) Held Back By Insufficient Growth Even After Shares Climb 39%

Winning Health Technology Group Co., Ltd. ( SZSE:300253 ) shareholders would be excited to see that the share price has...
Analysis Article • Aug 22

Winning Health Technology Group (SZSE:300253) May Have Issues Allocating Its Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
Analysis Article • Jul 03

These 4 Measures Indicate That Winning Health Technology Group (SZSE:300253) Is Using Debt Reasonably Well

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Analysis Article • May 03

Impressive Earnings May Not Tell The Whole Story For Winning Health Technology Group (SZSE:300253)

Winning Health Technology Group Co., Ltd. ( SZSE:300253 ) announced strong profits, but the stock was stagnant. Our...
Analysis Article • Mar 19

Is Winning Health Technology Group (SZSE:300253) A Risky Investment?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Analysis Article • Mar 01

Winning Health Technology Group Co., Ltd. (SZSE:300253) Held Back By Insufficient Growth Even After Shares Climb 25%

Winning Health Technology Group Co., Ltd. ( SZSE:300253 ) shareholders are no doubt pleased to see that the share price...
Analysis Article • Feb 28

Returns On Capital At Winning Health Technology Group (SZSE:300253) Paint A Concerning Picture

What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...

Earnings and Revenue Growth Forecasts

SZSE:300253 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20283,087299N/A4713
12/31/20272,726176N/A3863
12/31/20262,40257N/A3403
3/31/20262,159-365351532N/A
12/31/20252,106-374335555N/A
9/30/20252,165-308243501N/A
6/30/20252,398-60278546N/A
3/31/20252,63377182491N/A
12/31/20242,78288102408N/A
9/30/20243,17636039339N/A
6/30/20243,19537261385N/A
3/31/20243,209438-134168N/A
12/31/20233,163358-129185N/A
9/30/20233,123121-25382N/A
6/30/20233,18958-29624N/A
3/31/20233,09713-234107N/A
1/1/20233,093109-223100N/A
9/30/20222,85825854379N/A
6/30/20222,822333143461N/A
3/31/20222,851396171468N/A
1/1/20222,75037882368N/A
9/30/20212,658547106332N/A
6/30/20212,498528112312N/A
3/31/20212,333494212406N/A
12/31/20202,267491203390N/A
9/30/20202,08232981270N/A
6/30/20202,032311-4213N/A
3/31/20201,93935313213N/A
12/31/20191,908398N/A233N/A
9/30/20191,712384N/A117N/A
6/30/20191,561347N/A194N/A
3/31/20191,480320N/A161N/A
12/31/20181,439303N/A124N/A
9/30/20181,439288N/A91N/A
6/30/20181,330259N/A27N/A
3/31/20181,242243N/A-22N/A
12/31/20171,204229N/A80N/A
9/30/20171,059193N/A-57N/A
6/30/20171,011184N/A-26N/A
3/31/2017987523N/A121N/A
12/31/2016954519N/A140N/A
9/30/2016901522N/A158N/A
6/30/2016852517N/A101N/A
3/31/2016791158N/A26N/A
12/31/2015753153N/A79N/A
9/30/2015647142N/A-48N/A
6/30/2015607142N/A8N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300253 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).

Earnings vs Market: 300253 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 300253 is expected to become profitable in the next 3 years.

Revenue vs Market: 300253's revenue (13% per year) is forecast to grow slower than the CN market (16.3% per year).

High Growth Revenue: 300253's revenue (13% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300253's Return on Equity is forecast to be low in 3 years time (3.5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/12 13:57
End of Day Share Price 2026/06/12 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Winning Health Technology Group Co., Ltd. is covered by 9 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rui HanChina International Capital Corporation Limited
Zeyuan YangCitic Securities Co., Ltd.
Justin KwokGoldman Sachs